Company / Debt per Share
CG Oncology, Inc. Debt per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.04
FY2025
5-year range
$0.00 / $0.04
FY2024-FY2025
Trend
-
vs FY2024
Sector context
#78 of 82
Health Care
What the data says
Among 82 Health Care companies, CG Oncology, Inc. is in the top 5% for debt per share.
Based on SEC 10-K filings.
0.04 in FY2025.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 82This company $0.04 Sector average $151.48
▼
-100.0% below sector average
Key checks
Key Insights
- Ranks #78 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | - |
| FY2024 | $0.00 | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026